Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery

- DDR1 is a potential therapeutic target as it is implicated in organ fibrosis and several cancers.
- DDR1 has a characteristic kinase domain containing several functionally conserved residues.
- Homology modeling and docking studies of DDR1 demonstrates possibilities for computer aided drug discovery.